Nuvation Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Nuvation Bio Inc. (NUVB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-567.94-75.80-104.20-86.85-41.66
Depreciation & Amortization0.680.223.874.780.10
Stock Based Compensation32.2819.5116.299.272.20
Change in Working Capital-12.510.54-3.459.782.11
Change in Accounts Receivable-12.590.000.000.000.00
Change in Accounts Payable-1.650.07-1.791.860.03
Change in Other Working Capital1.74-0.070.293.972.08
Other Operating Activities417.08-0.076.395.062.35
Net Cash from Operating Activities-130.41-68.00-96.11-68.19-36.53
Investing Activities
Capital Expenditures-0.16-0.070.370.28-0.15
Acquisitions12.430.000.00624.770.00
Purchases of Investments0.00-703.37-520.31-609.30-70.18
Sales/Maturities of Investments0.00712.3563.81-454.39-70.18
Other Investing Activities110.440.000.000.000.00
Net Cash from Investing Activities122.708.9263.46-454.67-70.32
Financing Activities
Debt Repayment-4.550.000.000.000.00
Common Stock Issued4.890.631.333.79-135.66
Other Financing Activities0.000.250.390.31-2.52
Net Cash from Financing Activities0.330.631.33625.53133.14
Summary
Effect of Forex Changes on Cash0.450.000.000.000.00
Net Change in Cash-6.93-58.45-31.32102.6726.29
Cash at Beginning of Period42.65101.10132.4229.763.47
Cash at End of Period35.7242.65101.10132.423.47
Free Cash Flow-130.58-68.07-96.47-68.47-36.67